Use of ratiometrically designed nanocarrier targeting CDK4/6 and autophagy pathways for effective pancreatic cancer treatment
Cited by 68
Related Papers
Combination Chemo‐Immunotherapy for Pancreatic Cancer Using the Immunogenic Effects of an Irinotecan Silicasome Nanocarrier Plus Anti‐PD‐1
|Advanced Science|2021|132
Synergistic Chemoimmunotherapy Augmentation via Sequential Nanocomposite Hydrogel‐Mediated Reprogramming of Cancer‐Associated Fibroblasts in Osteosarcoma
|Advanced Materials|2023|65
Development of self-assembled multi-arm polyrotaxanes nanocarriers for systemic plasmid delivery in vivo
|Biomaterials|2018|41
Pulmonary Delivery of Specialized Pro-Resolving Mediators-Based Nanotherapeutics Attenuates Pulmonary Fibrosis in Preclinical Animal Models
|ACS Nano|2023|24
Iteratively Designed Nanocarrier for Cell Cycle Arrest, Immune Boost, and T Cell Access
|Research Square|2024|0